web analytics
4 C
Munich
Monday, December 5, 2022

Rising Biosciences Inc (OTCMKTS: RBII) Back in Track as Oxi Thyme Gains Traction

Rising Biosciences Inc (OTCMKTS: RBII) is making a dynamic move up the charts on a massive surge of volume after the Company announced the EPA has issued Establishment Number 96322-OH-3 for the company’s new 10,000 square foot bottling plant and corporate headquarters in Sandusky, OH. This is big news for Rising Biosciences which has experienced rapid growth in recent months having outgrown its original bottling plant. In the last week of August RBII stock was suspended “because of questions regarding the accuracy and adequacy of information in the marketplace about RBII and its common stock. ” RBII started trading again on September 8.

RBII is once again running northbound as investors accumulate. Before the suspension RBII was trading as high as $.0326 and has taken a serious haircut since. RBII is a growth story recently reporting $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. Described by many as the best and most affordable sanitization and disinfectant product on the market – All natural, EPA and CDC approved, Oxi Thyme utilizes an atomizing ULV (ultra-low volume) or HVLP (high volume, low pressure) fogging system which allows droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitize large areas quickly and efficiently leaving no toxic residue.

Sanitizing a Bar with Oxi-THYME - YouTubeRising Biosciences Inc (OTCMKTS: RBII) operates three distinct business units. The first business unit is a physician’s practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.

RBII Oxithymol™ is a proprietary system designed to sanitize and disinfect varying facilities in the current challenging environment, quickly and cost effectively. Utilizing a proprietary formulated EPA registered Hydrogen Peroxide disinfectant, developed with a surfactant, or surface active agent, Oxi Thyme improves efficiency by lowering surface tension. The addition of a surfactant and the use of an atomizing ULV (ultra-low volume) or HVLP (high volume, low pressure) fogging system allows the droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitizing large areas quickly and efficiently leaving no toxic residue.

To Find out the inside Scoop on RBII  subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RBIIRBII is already doing big numbers; In July RBII reported record revenue growth to nearly $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. “The activity over the last three months has been incredible”, said Hall. “We have already outgrown our original bottling plant and are in the process of building a second bottling facility in South Florida. Currently, we are operating in 14 states, servicing 74 regions from Anchorage, AK to Key West, FL, with more going on line each week.”

On September 11 RBII took off northbound after the Company announced the Environmental Protection Agency (EPA) has issued Establishment Number 96322-OH-3 for the company’s new 10,000 square foot bottling plant and corporate headquarters in Sandusky, OH.

RBII CEO Arthur Hall stated:  “We will begin bottling in our new plant by October 1st, starting with our new product, Oxy Blast 50 Post-Harvest Fruit and Vegetable Bactericide Disinfectant, that is being targeted to grocers and produce vendors nationwide, to safely sanitize and disinfect fresh fruits and vegetables. It is a variant of the Oxy Blast 50 Bactericide Disinfectant we currently use with the OxyThyme system. The company is very proud that the bactericide disinfectant product is also listed with the “Organic Materials Review Institute”, added Hall. OMRI is a private, nonprofit organization that determines whether or not a product qualifies as organic under the USDA’s National Organic Program (NOP). Goods that are found to comply are listed on the OMRI Brand Name Products List (BNPL). The list is used by certifiers, growers, manufacturers, and suppliers to confirm that an item is approved for organic use according to USDA rules.

We have a Big Pick Coming. Subscribe Right Now!

Currently coming back strong since the suspension RBII is one exciting story developing in small caps that is getting noticed as Oxi Thyme “it’s time to clean” gains serious traction. Described by many as the best and most affordable sanitization and disinfectant product on the market – All natural, EPA and CDC approved, Oxi Thyme utilizes an atomizing ULV (ultra-low volume) or HVLP (high volume, low pressure) fogging system which allows droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitize large areas quickly and efficiently leaving no toxic residue. RBII is a growth story recently reporting $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. RBII is moving northbound again after the Company announced the EPA has issued Establishment Number 96322-OH-3 for the company’s new 10,000 square foot bottling plant and corporate headquarters in Sandusky, OH. This is big news for Rising Biosciences which has experienced rapid growth in recent months having outgrown its original bottling plant. We will be updating on RBII when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with RBII.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in RBII either long or short and we have not been compensated for this article.

Ali Raza
A journalist, with experience in web journalism and marketing. Ali holds a master degree in finance and enjoys writing about cryptocurrencies and fintech. Ali’s work has been published on a number of cryptocurrency publications.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.